Why Teva Really Wants to Acquire Mylan
Teva Pharmaceutical Industries has just approached Mylan with a public takeover bid valued at $82 per share in cash and stock.
All Work
Chris Lange
Are Analysts and Investors Still Disappointed With Verizon Earnings?
Verizon Communications reported mixed first-quarter financial results Tuesday before the markets opened.
Has IBM Stopped the Bleeding With Earnings?
IBM reported mixed first-quarter financial after the markets closed Monday but reaffirmed its full-year guidance.
BioCryst Upgrade Almost Looks Misunderstood
The most recent analyst call by Merrill Lynch for BioCryst Pharmaceuticals may be very misunderstood for what it is.
Genetic Technologies Drives Ahead in the Fight Against Cancer
ThinkstockGenetic Technologies Limited (NASDAQ: GENE) has been making large strides in the area of women’s health recently with the opening of more centers that utilize the BREVAGenplus. Ultimately this will benefit women who are…
Why One Analyst Sees Large Upside in Facebook Ahead of Earnings
courtesy of Facebook Inc.Facebook, Inc. (NASDAQ: FB) will report its first-quarter financial results Wednesday after the market close. Thomson Reuters has consensus estimates of $0.40 in earnings per share (EPS) on $3.56 billion in…
Is Ampio at Risk of Imploding?
Ampio announced Monday that a Phase 3 for the treatment pain due to osteoarthritis of the knee did not reach its primary endpoint against a saline control.
What to Expect From IBM Earnings
IBM is scheduled to report its first-quarter financial results Monday after the markets close. Is a recovery in the works?
Why a Key Analyst Is Less Positive on Apple Ahead of Earnings
After seeing how other companies have dealt with strong currency headwinds, it is now time to see how Apple will handle this issue. Wells Fargo has given its opinion ahead of Apple’s earnings.
Why Groupon Is Already Returning Capital to Shareholders
Online coupon and daily deals giant Groupon looks like it is pulling out a huge win in a stake sale of its South Korean e-commerce business, Ticket Monster.
Royal Caribbean Disembarks Q1 on Weak Guidance
Royal Caribbean Cruises reported mixed first-quarter financial results Monday before the markets opened.
6 Top Tech Earnings Previews This Week: IBM, Google, Qualcomm, Microsoft, Amazon, Facebook
24/7 Wall St. has put together a preview of some of the larger companies in the tech sector reporting their quarterly results in the middle of April.
7 DIJA Earnings Previews This Week: Verizon, Boeing, Coca-Cola, McDonald’s, Caterpillar, 3M, P&G
24/7 Wall St. has put together a preview of some of the Dow Jones Industrial Average components reporting their financial results in the week ahead.
5 Big Biotechs Not Keeping Up at All With Hot Biotech Sector in 2015
The health care sector and biotech in particular have been on fire so far in 2015, but some biotech stocks in the group just are not carrying their weight.
Why S&P Raised Nokia on Alcatel-Lucent Merger
S&P, which is evaluating the Nokia and Alcatel-Lucent merger from a credit perspective, sees the combined companies in a positive light.
Are Small Cap Stocks Better Than Large Caps Again?
A Credit Suisse report sees some distinct advantages for small cap stocks in 2015, as headwinds are continuing to mount for large cap stocks.
Akebia Hits New Low After Pricing Secondary Offering
Akebia Therapeutics shares hit a new 52-week low after the company announced the pricing for its secondary offering.
Maybe Merrill Lynch Was Right on Synchrony Earnings
It appears that Merrill Lynch analysts Kenneth Bruce and Charlie Pratt were right when they downgraded Synchrony Financial in recent weeks.
Seagate Looks for Direction After Earnings
Seagate Technology reported mixed fiscal third-quarter financial results Friday before the markets opened.
Could Foreign Companies Help Block the Kraft-Heinz Merger
The Kraft-Heinz merger may come under fire from foreign competition. 24/7 Wall St. ponders how the competitors such as Nestlé will react.